Bg pattern

KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Patient Information Leaflet: Information for the Patient

Kinpeygo 4 mg, Modified Release Hard Capsules

budesonide

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Kinpeygo and what is it used for
  2. What you need to know before you take Kinpeygo
  3. How to take Kinpeygo
  4. Possible side effects
  5. Storage of Kinpeygo
  6. Contents of the pack and further information
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

1. What is Kinpeygo and what is it used for

Kinpeygo contains the active substance budesonide, a corticosteroid that acts mainly locally in the intestine to reduce inflammation associated with primary immunoglobulin A (IgA) nephropathy.

Kinpeygo is used to treat primary IgA nephropathy in adults from 18 years of age.

2. What you need to know before you take Kinpeygo

Do not take Kinpeygo:

  • If you are allergic to budesonide or any of the other ingredients of this medicine (listed in section 6).
  • If you have severe liver dysfunction, as indicated by your doctor.

Warnings and precautions

Consult your doctor or pharmacist before taking Kinpeygo:

  • If you are going to undergo surgery.
  • If you have liver problems.
  • If you are taking or have recently taken corticosteroids.
  • If you have had a recent infection.
  • If you have active or latent tuberculosis, fungal, bacterial, systemic, viral, or parasitic infections that are not being treated, or simple ocular herpes.
  • If you have high blood pressure.
  • If you have diabetes, or if someone in your family has had diabetes.
  • If you have bone fragility (osteoporosis).
  • If you have stomach ulcers.
  • If you have glaucoma (increased eye pressure) or cataracts, or if someone in your family has had glaucoma (increased eye pressure).

If you are in any of these situations, you may be at greater risk of experiencing side effects. Your doctor will decide what measures are appropriate and whether it is still suitable for you to take this medicine.

Be aware of side effects

If you experience blurred vision or other visual problems, contact your doctor. See section 4 for more information.

Chickenpox or measles

Diseases such as chickenpox and measles can be more serious if you are taking this medicine. If you have not had these diseases, stay away from people with chickenpox or measles while taking this medicine. Inform your doctor if you think you have contracted chickenpox or measles while taking this medicine.

Adrenal function tests

Kinpeygo may affect the results of adrenal function tests (ACTH stimulation test) requested by your doctor. Inform your doctor that you are taking Kinpeygo before undergoing any test.

Children and adolescents

Kinpeygo should not be used in children and adolescents under 18 years of age. The use of this medicine has not been studied in children under 18 years of age.

Other medicines and Kinpeygo

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines. This includes medicines obtained without a prescription and herbal products.

This is because Kinpeygo may affect the action of some medicines, and some medicines may affect Kinpeygo.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines:

Ketoconazole or itraconazole to treat fungal infections.

  • HIV medicines called "protease inhibitors", such as ritonavir, indinavir, and saquinavir.
  • Erythromycin, an antibiotic used to treat infections.
  • Ciclosporin, which is used to suppress the immune system.
  • Carbamazepine to treat epilepsy and neurological pain problems.
  • Cardiac glycosides, such as digoxin, used to treat heart conditions.
  • Diuretics to remove excess fluid from the body.

If you are in any of these cases (or are unsure), consult your doctor or pharmacist before taking Kinpeygo.

Using Kinpeygo with food and drinks

Do not eat grapefruit or drink grapefruit juice while taking Kinpeygo, as it may affect the action of the medicine.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Do not take this medicine during pregnancy without consulting your doctor first.

Do not take this medicine if you are breastfeeding unless you have consulted your doctor. Budesonide passes into breast milk in small amounts. Your doctor will help you decide whether to continue treatment and not breastfeed or to stop treatment while breastfeeding.

Driving and using machines

Kinpeygo is not expected to affect your ability to drive or use machines.

Kinpeygo contains sucrose

If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Kinpeygo

Follow the instructions for administration of this medicine exactly as indicated by your doctor. If in doubt, consult your doctor or pharmacist again.

How to take it

The recommended dose of Kinpeygo is 16 mg (4 capsules of 4 mg of Kinpeygo) once a day. It should be taken in the morning, at least 1 hour before eating.

  • The capsules should be swallowed whole with a glass of water.
  • Do not open, crush, or chew the capsules, as this may affect the release of the medicine. The capsules have a special coating to ensure that the medicine is released in the correct part of the intestine.

When treatment is to be discontinued, your doctor will reduce the dose to 8 mg (2 capsules of 4 mg of Kinpeygo) once a day for the last 2 weeks of treatment. If your doctor considers it necessary, the dose may be reduced to 4 mg once a day (1 capsule of 4 mg of Kinpeygo) for another 2 weeks.

If you take more Kinpeygo than you should

If you take more Kinpeygo than you should, consult your doctor or pharmacist immediately. Bring the pack with you.

If you have taken more than you should for a long time, the possible side effects listed in section 4 may appear.

If you forget to take Kinpeygo

If you forget to take a dose of Kinpeygo, wait and take the medicine the next day as usual.

Do not take a double dose to make up for the forgotten dose.

If you stop taking Kinpeygo

Do not stop taking Kinpeygo without consulting your doctor first. If you stop taking the medicine abruptly, you may become ill.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor if you notice any of the following side effects with this medicine:

Very common (may affect more than 1 in 10 people)

  • Skin rash or itching
  • Acne
  • Low potassium levels in the blood (hypokalemia)

Common (may affect up to 1 in 10 people)

  • High blood pressure
  • Swelling of arms or legs, such as in the ankles
  • Swelling of the face
  • Cushingoid features, such as rounded face, increased body hair, weight gain, and acne
  • Indigestion
  • Muscle cramps
  • Weight gain
  • Diabetes mellitus
  • Increased white blood cell count (detected by blood tests)

Rare (may affect up to 1 in 1,000 people)

  • Blurred vision

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. * By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Kinpeygo

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the label of the bottle. The expiry date is the last day of the month stated.

Do not store above 25°C.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the pack and further information

Composition of Kinpeygo

  • The active substance is budesonide. Each modified release hard capsule contains 4 mg of budesonide.
  • The other ingredients are:

Capsule content: sugar spheres (sucrose and corn starch), hypromellose, macrogol, citric acid monohydrate, ethylcellulose, medium-chain triglycerides, oleic acid (see also section 2 "Kinpeygo contains sucrose").

Capsule shell: hypromellose, macrogol, titanium dioxide (E171), methacrylic acid - methyl methacrylate copolymer, talc, dibutyl sebacate,

Printing ink: shellac, iron oxide black (E172).

Appearance of the product and pack contents

Kinpeygo 4 mg, modified release hard capsules are opaque capsules, 19 mm in length, with a white capsule shell and printed with "CAL10 4MG" in black ink.

The capsules are presented in a white high-density polyethylene (HDPE) bottle with a white polypropylene (PP) child-resistant closure and an induction seal.

This medicine is available in bottles containing 28 or 120 modified release hard capsules and in multipacks of 360 modified release hard capsules, which contain 3 bottles of 120 modified release hard capsules each.

Not all pack sizes may be marketed.

Marketing authorisation holder

STADA Arzneimittel AG

Stadastrasse 2-18

61118 Bad Vilbel

Germany

Manufacturer

Tjoapack Netherlands B.V.

Nieuwe Donk 9

4879 AC Etten-Leur

Noord-Brabant

Netherlands

STADA Arzneimittel AG

Stadastrasse 2 – 18

61118 Bad Vilbel

Germany

You can obtain further information on this medicine from the local representative of the marketing authorisation holder:

België/Belgique/Belgien

EG (Eurogenerics) NV

Tel: +32 24797878

Lietuva

UAB „STADA Baltics“

Tel: +370 52603926

STADA Bulgaria EOOD

Tel: +359 29624626

Luxembourg/Luxemburg

EG (Eurogenerics) NV

Tel: +32 24797878

Ceská republika

STADA PHARMA CZ s.r.o.

Tel: +420 257888111

Magyarország

STADA Hungary Kft

Tel.: +36 18009747

Danmark

STADA Nordic ApS

Tlf: +45 44859999

Malta

Pharma.MT Ltd.

Tel: + 356 21337008

Deutschland

STADAPHARM GmbH

Tel: +49 61016030

Nederland

Centrafarm B.V.

Tel.: +31 765081000

Eesti

UAB „STADA Baltics“

Tel: +370 52603926

Norge

STADA Nordic ApS

Tlf: +45 44859999

Ελλάδα

FΑRAN S.A.

Tel: +30 2106254175

Österreich

STADA Arzneimittel GmbH

Tel: +43 136785850

España

Laboratorio STADA, S.L.

Tel: +34 934738889

Polska

STADA Pharm Sp. z o.o.

Tel: +48 227377920

France

EG Labo - Laboratoires EuroGenerics

Tel: +33 146948686

Portugal

Stada, Lda.

Tel: +351 211209870

Hrvatska

STADA d.o.o.

Tel: +385 13764111

România

STADA M&D SRL

Tel: +40 213160640

Ireland

Clonmel Healthcare Ltd.

Tel: +353 526177777

Slovenija

Stada d.o.o.

Tel: +386 15896710

Ísland

STADA Nordic ApS

Tlf: +45 44859999

Slovenská republika

STADA PHARMA Slovakia, s.r.o.

Tel: +421 252621933

Italia

EG SpA

Tel: +39 028310371

Suomi/Finland

STADA Nordic ApS, Suomen sivuliike Puh/Tel: +358 207416888

Κúπρος

STADA Arzneimittel AG

Tel: +30 2106664667

Sverige

STADA Nordic ApS

Tel: +45 44859999

Latvija

UAB „STADA Baltics“

Tel: +370 52603926

United Kingdom (Northern Ireland)

STADA Arzneimittel AG

Tel: +49 61016030

Date of last revision of this leaflet:

Online doctors for KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES

Discuss questions about KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (0)
Doctor

Hocine Lokchiri

General medicine 21 years exp.

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Camera Book a video appointment
€58
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50
5.0 (29)
Doctor

Anna Biriukova

General medicine 6 years exp.

Dr Anna Biriukova is an internal medicine doctor with clinical experience in cardiology, endocrinology, and gastroenterology. She provides online consultations for adults, offering expert medical support for heart health, hormonal balance, digestive issues, and general internal medicine.

Cardiology – Diagnosis and treatment of:

  • High blood pressure, blood pressure fluctuations, and cardiovascular risk prevention.
  • Chest pain, shortness of breath, arrhythmias (tachycardia, bradycardia, palpitations).
  • Leg swelling, chronic fatigue, reduced exercise tolerance.
  • EKG interpretation, lipid profile evaluation, cardiovascular risk assessment (heart attack, stroke).
  • Post-COVID-19 cardiac monitoring and care.
Endocrinology – Diabetes, thyroid, metabolism:
  • Diagnosis and management of type 1 and type 2 diabetes, and prediabetes.
  • Individual treatment plans including oral medications and insulin therapy.
  • GLP-1 therapy– modern pharmacological treatment for weight management and diabetes control, including drug selection, monitoring, and safety follow-up.
  • Thyroid disorders – hypothyroidism, hyperthyroidism, autoimmune thyroid diseases (Hashimoto’s, Graves’ disease).
  • Metabolic syndrome – obesity, lipid disorders, insulin resistance.
Gastroenterology – Digestive health:
  • Abdominal pain, nausea, heartburn, gastroesophageal reflux (GERD).
  • Stomach and intestinal conditions: gastritis, irritable bowel syndrome (IBS), indigestion.
  • Management of chronic digestive disorders and interpretation of tests (endoscopy, ultrasound, labs).
General internal medicine and preventive care:
  • Respiratory infections – cough, colds, bronchitis.
  • Lab test analysis, therapy adjustments, medication management.
  • Adult vaccinations – planning, contraindications assessment.
  • Cancer prevention – screening strategies and risk assessment.
  • Holistic approach – symptom relief, complication prevention, and quality of life improvement.
Dr Biriukova combines internal medicine with specialist insight, offering clear explanations, personalised treatment plans, and comprehensive care tailored to each patient.
Camera Book a video appointment
€60
5.0 (29)
Doctor

Dmytro Horobets

Family medicine 7 years exp.

Dr. Dmytro Horobets is a licensed family medicine physician in Poland, specialising in endocrinology, diabetology, obesity management, gastroenterology, pediatrics, general surgery, and pain medicine. He offers online consultations for adults and children, providing personalised medical support for a wide range of acute and chronic health concerns.

Areas of expertise:

  • Endocrinology: diabetes type 1 and type 2, prediabetes, thyroid disorders, metabolic syndrome, hormonal imbalance.
  • Obesity medicine: structured weight management plans, nutritional counselling, obesity-related health risks.
  • Gastroenterology: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), liver and biliary conditions.
  • Pediatric care: infections, respiratory symptoms, digestive issues, growth and development monitoring.
  • General surgery support: pre- and post-surgical consultations, wound care, rehabilitation.
  • Pain management: chronic and acute pain, back pain, joint pain, post-traumatic pain syndromes.
  • Cardiovascular health: hypertension, cholesterol control, risk assessment for heart disease.
  • Preventive medicine: regular check-ups, health screenings, long-term management of chronic conditions.

Dr. Horobets combines evidence-based medicine with a patient-centred approach. He carefully evaluates each patient’s medical history and symptoms, offering clear explanations and structured treatment plans adapted to individual needs.

Whether you need help managing diabetes, tackling weight-related health issues, interpreting lab results, or receiving general family medicine support, Dr. Horobets provides professional online care tailored to your specific health goals.

Camera Book a video appointment
€60

Frequently Asked Questions

Is a prescription required for KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES?
KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES?
The active ingredient in KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES is budesonide. This information helps identify medicines with the same composition but different brand names.
Who manufactures KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES?
KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES is manufactured by Stada Arzneimittel Ag. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to KINPEYGO 4 mg PROLONGED-RELEASE HARD CAPSULES?
Other medicines with the same active substance (budesonide) include ENTOCORD 2 mg TABLETS AND SOLUTION FOR RECTAL SUSPENSION, ENTOCORD 3 mg MODIFIED-RELEASE CAPSULES, INTESTIFALK 2 mg/DOSE RECTAL FOAM. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media